Liver Cirrhosis
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Liver Diseases
Narrower: Liver Cirrhosis, Biliary 2
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Cannabidiol for liver cirrhosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver for liver cirrhosis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Faecal microbiota transplantation for liver cirrhosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fenofibrate for liver cirrhosis, biliary | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fenofibrate in Combination With Ursodeoxycholic Acid for liver cirrhosis, biliary | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.